BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2021 11:58:12 PM | Browse: 426 | Download: 927
 |
Received |
|
2021-02-22 19:39 |
 |
Peer-Review Started |
|
2021-02-22 19:41 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-06-04 03:28 |
 |
Revised |
|
2021-06-17 20:21 |
 |
Second Decision |
|
2021-10-18 06:46 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-10-18 09:24 |
 |
Articles in Press |
|
2021-10-18 09:24 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2021-12-07 04:35 |
 |
Publish the Manuscript Online |
|
2021-12-14 23:58 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management
|
Manuscript Source |
Invited Manuscript |
All Author List |
Beata Jabłońska, Paweł Szmigiel and Sławomir Mrowiec |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Beata Jabłońska, MD, PhD, Adjunct Professor, Department of Digestive Tract Surgery, Medical University of Silesia, Medyków 14, Katowice 40-752, Poland. bjablonska@poczta.onet.pl |
Key Words |
Pancreatic cyst; Pancreatic cystic neoplasm; Intraductal papillary mucinous neoplasm; Pancreatic cancer; Pancreatectomy; Guidelines |
Core Tip |
Intraductal papillary mucinous neoplasms (IPMNs) account about 1% of all pancreatic neoplasms and 25% of cystic neoplasms. We can distinguish three IPMN types: main duct-IPMN (MD-IPPMN), branch duct-IPMN (BD-IPMN), and mixed type-IPMN. Magnetic resonance imaging is the most useful approach for most IPMNs. Management depends on the type and radiological features of IPMNs. MD-IPMN is recommended for surgery. In BD-IPMN, management involves surgery or surveillance depending on the tumor size, cyst growth rate, solid components, main duct dilatation, high-grade dysplasia in cytology, the presence of symptoms (jaundice, new-onset diabetes, pancreatitis), and CA 19.9 serum level. The patient’s age and comorbidities should also be taken into consideration. Currently, there are different guidelines regarding the diagnostics and management of IPMNs: Sendai International Association of Pancreatology guidelines (2006), American Gastroenterological Association guidelines, revised international consensus Fukuoka guidelines (2012), revised international consensus Fukuoka guidelines (2017), and European evidence-based guidelines based on the European Study Group on Cystic Tumors of the Pancreas (2018). The experts of Verona Evidence-Based Meeting 2020 determined the most important further directions regarding guidelines on IPMN management. |
Publish Date |
2021-12-14 23:58 |
Citation |
Jabłońska B, Szmigiel P, Mrowiec S. Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management. World J Gastrointest Oncol 2021; 13(12): 1880-1895 |
URL |
https://www.wjgnet.com/1948-5204/full/v13/i12/1880.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v13.i12.1880 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345